G1 Therapeutics(GTHX) - 2024 Q1 - Quarterly Results
G1 TherapeuticsG1 Therapeutics(US:GTHX)2024-05-01 10:38

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024 G1 THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 001-38096 26-3648180 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 700 Park Offices Drive Suite 200 Research Triangle Park, NC 27709 (Add ...